SH2
Src homology 2
SH3
Src homology 3
Introduction
The acquisition of a mesenchymal phenotype by epithelial cells, a process termed epithelialmesenchymal (EM) transition , is required for morphogenesis and tissue remodeling during development (Guarino, 1995) . EM transitions are regulated in part through the actions of growth factors, the extracellular matrix and cell-cell adhesion proteins (Prieto and Crossin, 1995; Boyer et al., 2000) . Although tightly controlled during development, nonscheduled EM transitions in the adult organism can lead to the development and progression of human malignancies. In some cancers, this occurs through downregulation or mutation of E-cadherin or β-catenin (Behrens, 1999) . In addition, the dissolution of cadherin-based junctional complexes is also promoted by growth factors and their receptors and oncogenes such as Ras .
Hepatocyte growth factor (HGF) is a multifunctional factor, which, in addition to promoting epithelial cell growth and survival (Matsumoto and Nakamura, 1997) , is a potent modulator of EM transition (Weidner et al., 1993; Zhu et al., 1994) . In two-dimensional cultures, HGF stimulates the breakdown of cell-cell junctions and dispersal of sheets of epithelial cells, increasing their invasiveness (Stoker et al., 1987; Weidner et al., 1990) . HGF and its receptor, the Met receptor tyrosine kinase are deregulated or overexpressed in many human tumors (Lamorte and Park, 2001) . For example, amplification of the Met receptor tyrosine kinase has been found in gastric carcinomas (Nakajima et al., 1999) and gliomas (Koochekpour et al., 1997) . Activating point mutations within the kinase domain of the Met receptor tyrosine kinase have been characterized in hereditary and sporadic papillary renal carcinomas (Schmidt et al., 1997) . Moreover, overexpression of HGF and/or the Met receptor is associated with a poor prognosis for breast cancer patients (Jin et al., 1997; Ghoussoub et al., 1998; Camp et al., 1999) and transgenic mice overexpressing HGF develop tumors with metastatic lesions (Takayama et al., 1997; Otsuka et al., 1998) . These results underscore the importance of defining the mechanisms involved in promoting HGF-dependent EM transitions.
At the cellular level, stimulation of the Met receptor tyrosine kinase induces the remodeling of the actin cytoskeleton, cell spreading and the breakdown of cell-cell junctions (Ridley et al., 1995; Royal and Park, 1995; Potempa and Ridley, 1998; Royal et al., 2000) . Rac1 and Cdc42 are small GTP binding proteins involved in the remodeling of the actin cytoskeleton (Hall, 1998) and are activated in response to HGF (Royal et al., 2000) . Rac1 mediates the formation of lamellipodia and membrane ruffles whereas Cdc42 regulates the formation of filopodia (Hall, 1998) . Both Rac1 and Cdc42 are critical for the spreading of Madin Darby canine kidney (MDCK) epithelial cells stimulated with HGF (Ridley et al., 1995; Royal et al., 2000) . Rac1 activation in response to HGF is dependent on phosphatidylinositol 3'-kinase (PI3K) as the pretreatment of cells with inhibitors of PI3K blocks HGFstimulated activation of Rac1, cell spreading and dispersal (Royal and Park, 1995; Royal et al., 2000) .
In addition, inhibition of PI3K prevents the breakdown of adherens junctions following the stimulation of MDCK cells with HGF (Royal and Park, 1995; Potempa and Ridley, 1998) .
Studies using different model systems have shown that overexpression of CrkII or CrkL enhances cell migration (Klemke et al., 1998; Uemura and Griffin, 1999; Cho and Klemke, 2000; Petit et al., 2000; Spencer et al., 2000) . The CrkII adapter protein was originally identified as a viral oncogene, v-crk (Mayer et al., 1988) and is composed of one Src homology 2 (SH2) and two Src homology 3 (SH3) domains (SH2-SH3-SH3) (Reichman et al., 1992) . A second Crk-like gene, CrkL, was later isolated and it contains a similar modular structure as CrkII (ten Hoeve et al., 1993) . The Crk SH2 domain binds several tyrosine phosphorylated proteins: p130Cas, paxillin, Cbl and Gab1 (Feller, 2001) , while the amino terminal SH3 domain binds C3G, DOCK180 and Abl (Feller, 2001 ). More 6 recently, it was shown that DOCK180 can bind and activate Rac1 (Kiyokawa et al., 1998; Nolan et al., 1998) and genetic studies in C. elegans have demonstrated a role for CrkII and DOCK180 in the activation of Rac1 and cell migration (Reddien and Horvitz, 2000) .
While previous studies have examined the involvement of CrkII or CrkL in the migration of single cells, they did not address the involvement of CrkII or CrkL in the dispersal of sheets of epithelial cells, an event critical for metastasis. We demonstrate a role for CrkII and CrkL in the formation of lamellipodia, the spreading of colonies and the breakdown of adherens junctions in epithelial MDCK cells in response to HGF. In addition, we show that in the absence of HGF, CrkII or CrkL overexpression promotes lamellipodia formation, cell spreading and the breakdown of adherens junctions in MDCK cells and cell dispersal in well-differentiated breast carcinoma cells. 
Material and Methods

Materials and Antibodies
Indirect Immunofluorescence
Cells were fixed for 15 minutes in 3.7% formaldehyde and permeabilized with 0.2% Triton X-100. F or vinculin staining, cells were incubated for 10 min in 0.25x CSK buffer (2.5mM 1,4-piperazindiethansulfonic acid, pH 7.0, 75mM sucrose, 12.5mM NaCl, 0.75mM MgCl 2 and 0.125%
Triton X-100) at room temperature and then fixed as described above. Non-specific binding sites on the cells were blocked with 1% bovine serum albumin for 30 min. Primary and secondary antibodies were added successively, each for 30min, with extensive washing between each incubation. HA.11
antibodies were diluted 1:300, 9E10 antibodies were diluted 1:800, vinculin antibodies were diluted 1:400, Crk, CrkL, β-catenin and E-cadherin antibodies were diluted 1:200. Secondary antibodies were diluted 1:1000. Both AlexaFluor488 phalloidin and Texas Red-X phalloidin were used at a 1:1000 dilution. All reagents were diluted in PBS supplemented with 1mM MgCl 2 and 1mM CaCl 2 , with the exception of phalloidin, which was diluted in PBS supplemented with 0.2% Triton X -100. For experiments where cells were microinjected with rabbit immunoglobulin G, donkey αrabbit antibodies conjugated to AlexaFluor488 were used to detect injected cells. Coverslips were mounted onto glass slides using Immunofluore mounting medium (ICN, St Laurent, PQ, Canada). Images were acquired using a Retiga 1300 digital camera (QIMAGING, Burnaby, BC, Canada) and a Zeiss AxioVert 135 microscope (Carl Zeiss Canada Ltd., Toronto, ON, Canada). Image analysis was carried out using Northern Eclipse version 6.0 (Empix Imaging, Mississauga, ON, Canada).
Immunoprecipitation and Western Blotting
For co-immunoprecipitations, MDCK cells were serum starved for 20 hours in DMEM containing 0.02% FBS, stimulated with 100units/ml HGF and lysed in 1.0% Triton X-100 lysis buffer containing 50mM HEPES, pH 7.5, 150mM NaCl, 2mM EGTA, 1.5mM MgCl 2 , 1mM PMSF, 1mM
Na 3 VO 4 , 50mM NaF, 10µg/ml aprotinin and 10µg/ml leupeptin. Immunoprecipitations and western blotting were performed as described previously (Fixman et al., 1996) . The preparation of NP40-soluble and -insoluble fractions was carried out as described in (Potempa and Ridley, 1998) and equal amounts of protein were used for western blotting with E-cadherin antibodies.
Rac1 and Rap1 Pulldown Assays
Cells were grown for 36 hours in DMEM containing 10% FBS and serum starved in DMEM containing 0.02% FBS for 4 hours prior to HGF stimulation (100units/ml). Cells were lysed in 25mM HEPES, pH 7.5, 10mM MgCl 2 , 100mM NaCl, 1% NP-40 and 5% glycerol for the Rac1 pulldowns and in 50mM TrisCl, pH7.5, 10mM MgCl 2 , 200mM NaCl, 1% NP40 and 10% glycerol for the Rap1 pulldowns. 1mM PMSF, 1mM Na 3 VO 4 , 50mM NaF, 10µg/ml aprotinin and 10µg/ml leupeptin were included in the lysis buffers. GST-CRIB or GST-RalGDS fusion proteins were used for Rac1 or Rap1 pulldowns, respectively. Fusion proteins were prepared from bacteria as described previously (Royal et al., 2000) and 20µg of GST fusion protein were coupled to Glutathione Sepharose beads for 30min at room temperature. Following two washes of the Glutathione Sepharose beads, 700µg of cell lysate was added to the coupled fusion proteins and incubated for 60min at 4°C while rocking. Glutathione Sepharose beads were washed four times with lysis buffer and proteins were eluted by boiling in 2x
Laemmli sample buffer containing 100mM DTT. Samples were subjected to SDS-polyacrylamide gel electrophoresis and western blotted with Rac1 or Rap1 antibodies. Dr John Collard (The Netherlands Cancer Institute) provided GST-CRIB and Dr Johannes Bos (University Medical Centre Utrecht)
provided GST-RalGDS.
Results
CrkII associated proteins in MDCK cells
To examine the molecular mechanisms that regulate EM transitions, we have used MDCK kidney epithelial cells as a model system. In response to HGF, colonies of MDCK epithelial cells undergo multiple morphological changes leading to an EM transition and cell dispersal. This occurs as a series of sequential events where the centrifugal spreading of cells within the colony is concomitant with the breakdown of cell-cell junctions and the acquisition of a motile mesenchymal phenotype (Ridley et al., 1995; Royal and Park, 1995; Potempa and Ridley, 1998) . Both the CrkII and CrkL adapter proteins coordinate cell motility (Klemke et al., 1998; Uemura and Griffin, 1999; Cho and Klemke, 2000; Petit et al., 2000; Spencer et al., 2000) , yet their involvement in the regulation of EM transitions has not been addressed. We and others have demonstrated that following activation of the Met receptor tyrosine kinase, CrkII and CrkL are recruited into Met-dependent signaling complexes (Garcia-Guzman et al., 1999; Garcia-Guzman et al., 2000; Lamorte et al., 2000; Sakkab et al., 2000) . CrkII in the absence of stimulation and its association was enhanced following HGF stimulation ( Figure   1B ). Similar levels of CrkII were immunoprecipitated in each sample ( Figure 1B ).
A CrkI SH3 domain mutant impairs HGF induced cell spreading
To examine the potential role of CrkII and CrkL in the early biological events following HGF stimulation, MDCK cells were microinjected with empty vector or with plasmids encoding a CrkI protein with a mutation in its SH3 domain (CrkI W170K) or with mutations in both its SH2 and SH3 domains (CrkI R38K/W170K). CrkI is an alternatively spliced form of CrkII that lacks the carboxyterminal SH3 domain. The CrkI W170K proteins contains a point mutation in its amino-terminal SH3 domain which abolishes Crk binding to proline rich containing proteins (Tanaka et al., 1995) . This Crk mutant contains a functional SH2 domain that interacts with tyrosine phosphorylated proteins and acts as a dominant negative mutant, inhibiting the activation of ERK-1 in cells expressing an oncogenic form of Abl (Tanaka et al., 1995) . In colonies of MDCK cells microinjected with vector ( with DOCK180 and C3G, which activate Rac1 (Kiyokawa et al., 1998; Nolan et al., 1998) and Rap1 (Gotoh et al., 1995) , respectively. While we were unable to detect the association of DOCK180
with CrkII or CrkL (our unpublished results), the association of C3G with CrkII was enhanced in MDCK cells overexpressing CrkII ( Figure 4D ). To establish if downstream effectors were activated in MDCK cells overexpressing CrkII, we evaluated Rac1-GTP levels by pulldown assays using GST-PAK, and Rap1-GTP levels by pulldown assays using GST-RalGDS. In MDCK cells overexpressing
CrkII, Rac1-GTP levels ( Figure 4C ) and Rap1-GTP levels ( Figure 4E ) were elevated, in comparison with parental cells.
Rac1 but not Rap1 is required for CrkII induced lamellipodia formation and cell spreading
The activation of Rac1 is required for HGF-induced lamellipodia formation and cell spreading (Ridley et al., 1995; Royal et al., 2000) , CrkII-stimulated cell migration (Klemke et al., 1998) and
CrkII-stimulated lamellipodia formation in single cells (Dolfi et al., 1998; Klemke et al., 1998) . In addition, Rap1 regulates integrin-mediated cell adhesion (Bos et al., 2001 ) and cell spreading (Ohba et al., 2001) . We proceeded to determine whether Rac1 and/or Rap1 were required for CrkII-induced (Gumbiner, 2000) ). The breakdown of adherens junctions is a necessary pre-requisite for cell dispersal (Tsukamoto and Nigam, 1999) . Therefore, we compared the localization of β-catenin in vector and CrkII overexpressing T47D cells. While vector containing T47D cell colonies exhibited well defined β-catenin staining at cell-cell junctions ( Figure 6C, b) , β-catenin staining was absent from the membrane of cells in dispersed T47D
colonies overexpressing CrkII ( Figure 6C, d, arrowhead) . Moreover, reduced β-catenin staining was observed at cell-cell junctions in non-dispersed T47D cells overexpressing CrkII ( Figure 6C , d, arrow).
Hence, the overexpression of CrkII promotes the loss of β-catenin containing adherens junctions in T47D colonies and enhances cell dispersal.
In contrast to T47D cells ( Figure 7C , b, arrows), compared to noninjected cells that showed no reduction in β-catenin at cell-cell junctions ( Figures 7C, b) . Rac1 is present at cell-cell junctions in MDCK cells (Royal et al., 2000) and Rac1 activity is involved in the assembly and breakdown of adherens junctions (Braga, 2000) . In cells microinjected with CrkII plasmids ( Figure 7D, a) , Rac1 localization to cell-cell junctions was decreased and displayed a diffuse cytoplasmic localization ( Figure 7D, b) , whereas in noninjected cells, endogenous Rac1 was retained at cell-cell junctions ( Figure 7D, b) . The data presented in Figures 6 and 7 demonstrates that both CrkII and CrkL can stimulate the loss of epithelial adherens junctions and alter Rac1 localization.
ZO-1 is retained at cell-cell junctions in MDCK cells overexpressing CrkII
We have previously shown that in MDCK cells, the HGF-stimulated turnover of adherens junctions corresponds with cell spreading and precedes the loss of tight junctions (Royal and Park, 1995) . Although MDCK cells overexpressing CrkII displayed extensive cell spreading, ZO-1 was retained at cell-cell junctions ( Figure 8A, d) , as with the parental MDCK cells ( Figure 8A, b) .
However, a minority of MDCK cells microinjected with CrkII plasmids dispersed ( Figure 8B , c). These cells exhibited loss of ZO-1 staining at cell-cell contacts ( Figure 8B , b, arrow) and showed punctate ZO-1 staining within the cytoplasm ( Figure 8B, b) . In contrast, T47D cells lack ZO-1 containing tight junctions (our unpublished results) and the loss of β-catenin containing adherens junctions in cells overexpressing CrkII promotes cell dispersal and conversion to a mesenchymal like phenotype ( Figure   6A ).
Reorganization of focal adhesions in cells overexpressing CrkII
The spreading and dispersal of epithelial colonies requires the reorganization of the actin cytoskeleton and the assembly of nascent focal adhesions/complexes to strengthen adhesion to the extracellular matrix (Sastry and Burridge, 2000) . MDCK and T47D cells overexpressing CrkII were stained with vinculin antibodies and phalloidin to visualize focal adhesions and the actin cytoskeleton, 
Discussion
The modulation of epithelial junctions and cell migration occurs during normal embryonic development and participates in the dispersal of tumor cells . The Met receptor tyrosine kinase is deregulated in many human tumors (Lamorte and Park, 2001 ) and is one of the predominant mediators of EM transition (Weidner et al., 1993; Zhu et al., 1994) . Although several receptor tyrosine kinases that are deregulated in human tumors contribute to the modulation of epithelial junctions, the precise mechanism regulating this loss is not completely understood . The results presented here demonstrate that the CrkII and CrkL adapter proteins play an important role in the spreading and breakdown of epithelial cell-cell adherens junctions in colonies of epithelial cells (Figure 10 ), processes critical for epithelial cell dispersal.
Crk adapter proteins are required for HGF-mediated cell spreading
The ability of a CrkI SH3 domain mutant (W170K) to block HGF induced cell spreading and lamellipodia formation (Figure 2A ) suggests that the coupling of Crk SH2 and SH3 domains with upstream and downstream binding proteins is an important event required for HGF-induced cell spreading. The CrkI SH3 mutant contains a SH2 domain but lacks functional SH3 domains, thereby acting as an isolated SH2 domain. Consistent with this, the CrkI W170K mutant competes with CrkII and CrkL for the binding to tyrosine phosphorylated proteins ( Figure 2B ). The SH2 domains of CrkII and CrkL prefer a YXXP motif and bind the same proteins where tested (Feller, 2001) . This is further supported by our data demonstrating that both CrkII and CrkL bind similar phosphotyrosine-containing The Crk SH3 domain interacts with several proteins including DOCK180, which binds and activates Rac1 (Erickson et al., 1997; Kiyokawa et al., 1998) and C3G, an exchange factor for Rap1 (Gotoh et al., 1995) . Consistent with a role for Crk in HGF-dependent cell spreading, Rac1 activity is required for both CrkII-and HGF-stimulated cell spreading and remodeling of the actin cytoskeleton ( Figure 5 and (Ridley et al., 1995; Royal et al., 2000) , respectively). Moreover, Rac1 activity is elevated in MDCK cells overexpressing CrkII, to levels similar to those observed following HGF stimulation ( Figure 4C ). Although DOCK180 has been shown to activate Rac1 (Kiyokawa et al., 1998; Nolan et al., 1998) , we have been unable to co-immunoprecipitate either CrkII or CrkL with DOCK180 in MDCK or T47D cells (our unpublished results). Moreover, a farnesylated form of DOCK180 which promotes cell spreading in fibroblasts (Kiyokawa et al., 1998) Figure 4D ) and enhanced Rap1 activity ( Figure 4E ). However, whereas a dominant negative Rac1 mutant inhibited Crk-or HGF-induced cell spreading, the overexpression of a dominant negative Rap1 mutant failed to do so ( Figure 5 ). Although we show that activation of Rap1
is not required for cell spreading downstream of CrkII, Rap1 may be important for cell migration, morphogenesis and/or sustained ERK activation (Bos et al., 2001) , processes not evaluated here.
We have shown that in MDCK cells, CrkII binds multiple phosphotyrosine-containing proteins including Cbl, Gab1, paxillin and p130Cas ( Figure 1B ) and that these interactions are increased with distinct temporal profiles following HGF stimulation ( Figure 1B) . In response to HGF, the binding to one or all of these proteins may target CrkII to the membrane and/or other cellular compartments,
where Crk SH3 binding proteins can activate Rac1 and Rap1. CrkII and p130Cas each promote the formation of lamellipodia (Dolfi et al., 1998; Klemke et al., 1998) and enhance cell migration when overexpressed in dispersed COS cells (Klemke et al., 1998) following HGF stimulation. This is consistent with the ability of CrkII SH2 or SH3 domain mutants to abolish stress fiber formation in fibroblasts (Nakashima et al., 1999) . Moreover, PC12 cells expressing v-Crk display enhanced stress fiber and focal adhesion formation and v-Crk activated Rho-kinase (Altun-Gultekin et al., 1998) . Pharmacological inhibition of Rho-kinase using Y27632 decreased stress fiber formation in MDCK cells microinjected with CrkII or CrkL but failed to inhibit cell spreading (our unpublished results). We concluded that Rho-kinase activity and stress fiber formation are dispensable for CrkII and CrkL-stimulated cell spreading.
Crk adapter proteins stimulate the breakdown of epithelial adherens junctions
We have demonstrated for the first time that both CrkII and CrkL induce the loss of epithelial adherens junctions when overexpressed ( Figures 6C and 7) . Moreover, cells microinjected with the CrkI SH3 mutant and stimulated with HGF retain cortical actin (Figure 2A , e) demonstrating that this mutant blocks the HGF-mediated loss of adherens junctions. In support of a role for Crk-dependent loss of adherens junctions, less E-cadherin and β-catenin are present in the insoluble compartment of MDCK cells overexpressing CrkII, in comparison with control cells ( Figure 7B and our unpublished results). Rac1 is involved in both the assembly and disassembly of adherens junctions (Braga, 2000) and regulates the clathrin-independent endocytosis of E -cadherin (Akhtar and Hotchin, 2001 ). In colonies of MDCK cells, Rac1 is localized to cell-cell junctions and is translocated to lamellipodia following stimulation of cells with HGF (Royal et al., 2000) . In cells microinjected with CrkII, Rac1 is lost from cell-cell junctions and translocates to the cytoplasm ( Figure 7D, b) . ARF6 is required for the targeting of Rac1 to the membrane (Radhakrishna et al., 1999) and for HGF-stimulated E-cadherin internalization and migration (Palacios et al., 2001) . Moreover, overexpression of ARNO, an ARF6 exchange factor, stimulates Rac1 activity, lamellipodia formation and cell dispersal in MDCK cells (Santy and Casanova, 2001 ). Hence, it will be important to establish the ability of CrkII and CrkL to regulate ARF activity through its ability to associate with protein complexes such as paxillin, which binds ARF GTPase activating proteins (reviewed in (Turner et al., 2001) ).
The ability of epithelial cells to detach from neighboring cells is a prerequisite for tumor cell invasion. Although the overexpression of CrkII in stable lines of MDCK cells promotes cell spreading ( Figure 4A ) together with the loss of adherens junctions ( Figure 7A ), MDCK cells remain in colonies and retain tight junctions as visualized by ZO-1 ( Figure 8A ). In contrast, the overexpression of CrkII in a well-differentiated breast carcinoma cell line T47D promotes cell dispersal ( Figure 6A) . Notably, T47D cells lack tight junctions containing ZO-1 (our unpublished results) and the loss of adherens junctions following CrkII overexpression ( Figure 6C ) is sufficient to promote cell dispersal and a mesenchymal transition ( Figure 6A ). Several invasive breast cancer cell lines show loss of ZO-1 (Sommers et al., 1994) and one study demonstrated loss of heterozygosity in ZO-1 in 23% of breast cancer patients and reduced or no ZO-1 staining in 69% of patients (Hoover et al., 1998) . Hence, the loss of adherens junctions and ZO-1 containing tight junctions may predispose cells to dispersal following deregulation of signaling pathways involving Crk.
In conclusion, we have demonstrated that CrkII and CrkL are required for HGF-mediated cell spreading, lamellipodia formation and breakdown of adherens junctions (Figure 10 ). Furthermore, we have shown for the first time that CrkII and CrkL each promote the loss of adherens junctions which contributes to induce an EM-like transition (Figure 10 ), events critical for tumor cell dispersal and invasion. Our data, together with that demonstrating that CrkII and CrkL enhance cell migration (Klemke et al., 1998; Uemura and Griffin, 1999; Cho and Klemke, 2000; Hemmeryckx et al., 2001) , underscores the importance of Crk adapter proteins in cancer and highlights their suitability as therapeutic targets. Rap1 activity was measured using GST-RalGDS exactly as described in (C) for Rac1. 
